4qpf
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 4qpf is ON HOLD | + | The entry 4qpf is ON HOLD until Paper Publication |
Authors: Ebetino, F.H., Lundy, M., Kwaasi, A.A., Dunford, J.E., Duan, Z., Triffitt, J., Mazur, A., Jeans, G., Barnett, B.L., Russell, R.G.G. | Authors: Ebetino, F.H., Lundy, M., Kwaasi, A.A., Dunford, J.E., Duan, Z., Triffitt, J., Mazur, A., Jeans, G., Barnett, B.L., Russell, R.G.G. | ||
Description: New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption | Description: New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption | ||
Revision as of 08:17, 10 September 2014
Unreleased structure
The entry 4qpf is ON HOLD until Paper Publication
Authors: Ebetino, F.H., Lundy, M., Kwaasi, A.A., Dunford, J.E., Duan, Z., Triffitt, J., Mazur, A., Jeans, G., Barnett, B.L., Russell, R.G.G.
Description: New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption
